Bank of New York Mellon Corp Has $36.89 Million Position in Maximus, Inc. (NYSE:MMS)

Bank of New York Mellon Corp cut its stake in shares of Maximus, Inc. (NYSE:MMSFree Report) by 5.2% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 540,935 shares of the health services provider’s stock after selling 29,805 shares during the period. Bank of New York Mellon Corp owned 0.96% of Maximus worth $36,886,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of MMS. Norges Bank bought a new position in shares of Maximus during the fourth quarter worth approximately $71,443,000. SG Capital Management LLC acquired a new position in Maximus during the 4th quarter worth about $30,285,000. Federated Hermes Inc. lifted its holdings in Maximus by 74.8% during the 4th quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider’s stock worth $65,912,000 after buying an additional 377,705 shares during the period. Reinhart Partners LLC. raised its position in shares of Maximus by 65.4% in the 1st quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider’s stock worth $62,156,000 after acquiring an additional 360,365 shares in the last quarter. Finally, Squarepoint Ops LLC acquired a new position in Maximus during the 4th quarter worth approximately $22,661,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Performance

NYSE:MMS opened at $72.40 on Tuesday. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The business has a fifty day simple moving average of $71.65 and a two-hundred day simple moving average of $70.90. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.84 and a quick ratio of 1.84. The company has a market capitalization of $4.08 billion, a P/E ratio of 14.39 and a beta of 0.61.

Maximus (NYSE:MMSGet Free Report) last posted its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The company had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the company earned $1.57 earnings per share. The firm’s quarterly revenue was up 1.0% on a year-over-year basis. On average, analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.66%. Maximus’s dividend payout ratio is currently 23.86%.

Insider Transactions at Maximus

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the company’s stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the transaction, the director owned 14,205 shares in the company, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, May 15th.

Read Our Latest Analysis on Maximus

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Recommended Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.